Report Highlights

U.S. CBD Plant Nutrients: Market Overview

The U.S. CBD plant nutrients market has been fundamentally shaped by the Agricultural Improvement Act of 2018, commonly known as the 2018 Farm Bill, which reclassified hemp — defined as cannabis with less than 0.3% THC on a dry weight basis — as an agricultural commodity rather than a controlled substance. This reclassification unlocked access to USDA commodity programmes, crop insurance, and conventional agricultural lending for hemp farmers, catalysing a rapid expansion in licensed cultivation acreage that peaked at 511,442 acres in 2019 before stabilising into a more commercially disciplined base of approximately 90,000 acres by 2023. The nutrient products market grew directly in proportion to this licensed acreage, with growers requiring purpose-formulated inputs to maximise cannabinoid yield per acre.

Government policy has been the dominant structural force in this market, while the private sector has led product innovation and channel development. The USDA Agricultural Marketing Service administers the federal hemp programme under 7 CFR Part 990, setting THC testing protocols that indirectly influence nutrient strategies — high-nitrogen inputs in late flowering stages can suppress cannabinoid-to-THC ratios, making precision nutrient management commercially critical. State departments of agriculture operate parallel programmes with additional input restrictions, particularly in Oregon and Colorado, where integrated pest management requirements have elevated demand for certified organic and biological nutrient lines. Private companies such as Hawthorne Gardening Company have built dedicated hemp nutrient portfolios precisely in response to these regulatory conditions.

Policy-Driven Growth in CBD Plant Nutrients

Three specific policy mechanisms are actively driving demand in this market. First, the USDA's Farm Service Agency Noninsured Crop Disaster Assistance Program (NAP), as expanded under the 2018 Farm Bill, now covers hemp, creating a financial safety net that has increased grower willingness to invest in premium nutrient programmes rather than cutting input costs. NAP-eligible hemp farms in Kentucky and Tennessee have demonstrably shifted toward higher-cost controlled-release fertilizer products from General Hydroponics and Botanicare, because crop insurance coverage reduces the financial risk of upfront input expenditure. This mechanism translates directly into average revenue per acre of nutrient inputs increasing by an estimated 18% since 2020 among insured operations.

Second, the USDA's Organic Certification Cost Share Program (OCCSP), administered through state departments of agriculture, reimburses up to 75% of organic certification costs — capped at USD 750 per operation — for hemp farms seeking USDA National Organic Program status. This subsidy has lowered the financial barrier to organic compliance, expanding the addressable market for certified organic nutrient products including those from Raw Organics and Aurora Innovations. Third, Colorado's Senate Bill 21-087 mandated a state industrial hemp regulatory programme that includes mandatory soil testing and input reporting for licensed cultivators, creating a compliance-driven demand for precision nutrient formulations and diagnostic soil amendment products specifically calibrated to Colorado's alkaline soil conditions.

Regulatory Barriers and Compliance Costs

The primary regulatory barrier facing nutrient manufacturers in this market is the absence of a unified federal registration pathway for hemp-specific plant nutrient products. The EPA's Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) governs pesticide-adjacent products, but fertilizers are regulated under a fragmented state-by-state system administered through individual state departments of agriculture, each of which requires separate product registration. A single national nutrient product launch requires compliance with up to 50 individual state registration processes, with fees ranging from USD 100 to USD 1,500 per product per state and approval timelines spanning six to eighteen months. This structural barrier disproportionately advantages large incumbents like Hawthorne Gardening and disadvantages smaller specialty formulators attempting national market entry.

A second significant barrier is the EPA's ongoing review of whether hemp-derived biological stimulants qualify as pesticides under FIFRA Section 2(u), a classification question that has left multiple biostimulant products — including mycorrhizal inoculants and seaweed-derived growth regulators marketed specifically for CBD hemp — in a regulatory grey zone since 2021. Companies holding these products face potential mandatory reformulation or withdrawal if EPA issues an adverse determination. Additionally, the USDA's Agricultural Marketing Service imposes a mandatory pre-harvest THC testing protocol under 7 CFR 990.71 that requires growers to sample and test within 30 days of harvest, and nutrient timing errors that elevate THC above the 0.3% threshold result in mandatory crop destruction — a compliance risk that forces growers to purchase conservative, well-documented nutrient products rather than experimental inputs.

Policy-Created Opportunities in CBD Plant Nutrients

The most immediately actionable policy-created opportunity is the USDA's Specialty Crop Block Grant Program (SCBGP), which allocates federal funds to state departments of agriculture for programmes that enhance the competitiveness of specialty crops — a category that now explicitly includes hemp following guidance issued by USDA's Agricultural Marketing Service in 2021. States including Kentucky, Oregon, and North Carolina have used SCBGP funds to commission hemp-specific soil fertility research and extension services, generating state-validated nutrient management recommendations that effectively function as procurement specifications for cooperating growers. Nutrient manufacturers whose formulations align with published state extension guidelines gain a significant channel advantage in these high-acreage states.

A second opportunity is emerging from the anticipated reauthorisation of the Farm Bill, expected in 2025 or 2026, which is forecast to include dedicated research funding under a revised hemp title addressing CBD-specific agronomy. Industry coalitions including the U.S. Hemp Roundtable and Vote Hemp have formally submitted recommendations to the Senate Agriculture Committee requesting inclusion of hemp precision nutrient management within USDA Sustainable Agriculture Research and Education (SARE) grant eligibility. If enacted, SARE-funded demonstration trials using commercially available nutrient products from participating manufacturers will generate third-party validation data — the single most persuasive sales tool for agronomically conservative hemp growers currently relying on general agricultural fertilizers rather than purpose-formulated CBD hemp nutrition programmes.

Market at a Glance

Leading Market Participants

• Hawthorne Gardening Company
• Aurora Innovations
• Raw Organics
• General Hydroponics
• Botanicare
• Hydrofarm Holdings Group
• Growtek
• Advanced Nutrients
• Canna USA
• True Liberty Bags (Nutrient Division)

Regulatory and Policy Environment

The centrepiece legislation governing this market is the Agricultural Improvement Act of 2018 (Public Law 115-334), which vested the USDA with primary federal authority over hemp production and directed the development of a federal hemp production programme codified at 7 CFR Part 990. The USDA Agricultural Marketing Service is the responsible agency, overseeing state and tribal plan approvals, THC testing protocols, and grower licensing requirements. Key compliance obligations directly affecting nutrient manufacturers include the requirement that all inputs used on hemp destined for food or dietary supplement use must comply with FDA's 21 CFR Part 111 current Good Manufacturing Practice requirements where applicable, and growers operating under USDA-approved state plans must maintain records of all crop inputs for a minimum of three years. Compared to regional peers, the U.S. framework is significantly more permissive than Canada's Cannabis Act administered by Health Canada, which imposes federal product approval requirements on all agricultural inputs used in licensed cannabis cultivation, but less harmonised than the EU's emerging hemp cultivation framework under Regulation (EU) 2021/2115.

The FDA's parallel jurisdiction over CBD as a food ingredient under 21 U.S.C. 321 creates an unresolved regulatory tension directly affecting nutrient market dynamics. Because FDA has not issued a final rule permitting CBD in food or dietary supplements — despite issuing a statement of enforcement discretion in January 2023 — hemp farmers face uncertainty about which crop use categories will remain commercially viable, creating hesitancy in long-term input investment. The anticipated 2025–2026 Farm Bill reauthorisation is expected to include a provision directing FDA to issue final CBD food safety rules within 18 months of enactment, a deadline that would materially resolve the demand outlook for CBD hemp cultivation inputs. The DEA's interim final rule on hemp derivatives published in August 2020 remains in effect and continues to affect how nutrient companies can market products for "hemp" versus "cannabis" applications across their customer base.

Long-Term Policy Outlook for U.S. CBD Plant Nutrients

By 2032, the most consequential policy development for CBD plant nutrients will be the resolution of FDA's CBD food ingredient status. A positive final rule — which the Consumer Healthcare Products Association and American Herbal Products Association have both formally petitioned FDA to issue before the end of 2025 — would unlock the dietary supplement and functional food channels for CBD products, driving a second wave of licensed hemp cultivation expansion and a proportional increase in premium nutrient demand. Hawthorne Gardening Company and Aurora Innovations have both indicated in investor communications that their hemp nutrient portfolio scaling decisions are explicitly contingent on FDA's ruling, confirming that a single regulatory action will determine whether this market achieves its high-growth trajectory or plateaus at moderate expansion.

A second structural policy shift expected before 2032 is the potential rescheduling or descheduling of cannabis under the Controlled Substances Act, following the DEA's proposed rulemaking published in May 2024 to move cannabis from Schedule I to Schedule III. While hemp CBD operates outside the CSA framework, Schedule III reclassification would reduce legal and reputational risk for agricultural retailers and distributors handling cannabis-adjacent products, materially expanding the conventional retail and co-operative distribution channels available to CBD hemp nutrient manufacturers. State-level policy convergence — particularly the adoption of uniform input registration standards across the ten largest hemp-producing states — is also projected under a USDA-facilitated interstate compact being developed through the National Association of State Departments of Agriculture, which would eliminate the current multi-state registration burden and lower barriers for mid-tier specialty nutrient manufacturers.

Market Segmentation

By Product Type

• Nitrogen-Based Fertilizers
• Phosphorus and Potassium Blends
• Calcium-Magnesium Supplements
• Organic and Biological Nutrients
• Micronutrient and Trace Element Formulations
• pH Buffers and Soil Conditioners

By Cultivation Method

• Outdoor Field Cultivation
• Indoor Hydroponic Systems
• Greenhouse and Controlled Environment
• Aeroponic Systems
• Aquaponic Integration

By Form

• Liquid Concentrates
• Water-Soluble Powders
• Granular Slow-Release
• Foliar Sprays
• Tablet and Spike Formats

By End User

• Licensed Hemp Farmers
• Indoor Commercial Cultivators
• Research and University Trial Farms
• Greenhouse Operators
• Contract Extraction Facility Growers

Frequently Asked Questions

Q1. What federal agency regulates agricultural inputs used in licensed hemp cultivation in the United States? ▼

The USDA Agricultural Marketing Service oversees the federal hemp production programme under 7 CFR Part 990, while the EPA administers pesticide-related product registration under FIFRA. Fertilizer products themselves are regulated at the state level, with no single federal fertilizer registration authority.

Q2. How does the 0.3% THC compliance threshold affect nutrient purchasing decisions by hemp growers? ▼

Nutrient timing errors — particularly excess nitrogen applied during late flowering — can elevate THC concentrations above the 0.3% federal threshold, triggering mandatory crop destruction under USDA rules. This compliance risk leads growers to prioritise documented, low-risk nutrient formulations over unvalidated experimental products.

Q3. What is the current status of the USDA's federal hemp production programme and when does it require reauthorisation? ▼

The current USDA federal hemp programme operates under the 2018 Farm Bill, which expired in September 2023 and has been operating under successive continuing resolutions. Reauthorisation through a new Farm Bill is expected in 2025 or 2026 and is anticipated to include updated hemp-specific provisions.

Q4. Does the FDA's position on CBD in food and dietary supplements affect the CBD plant nutrients market? ▼

FDA's failure to issue a final rule permitting CBD as a food ingredient creates downstream demand uncertainty for licensed hemp cultivation and its associated input markets. A positive FDA ruling is expected to catalyse a second wave of hemp acreage expansion that would directly increase nutrient product demand.

Q5. Are organic nutrient products required for hemp certified under USDA's National Organic Program? ▼

Yes — hemp farms seeking USDA NOP organic certification must use only inputs permitted under the National List of Allowed and Prohibited Substances at 7 CFR Part 205. Synthetic fertilizers are prohibited under NOP, restricting certified organic hemp growers exclusively to approved biological and mineral nutrient sources.